-
公开(公告)号:EP3782639A1
公开(公告)日:2021-02-24
申请号:EP20197224.7
申请日:2016-12-08
发明人: BAIK, Andrew , CYGNAR, Katherine
摘要: Compositions and methods for treating lysosomal storage diseases are disclosed. Biotherapeutic complexes containing an internalization effector binding domain and a lysosomal replacement enzyme activity are disclosed. The biotherapeutic complexes are capable of entering cells, segregating to the lysosome, and delivering the replacement enzyme activity to the lysosome.
-
公开(公告)号:EP4423119A1
公开(公告)日:2024-09-04
申请号:EP22818964.3
申请日:2022-10-27
发明人: SABIN, Leah , KYRATSOUS, Christos , PEFANIS, Evangelos , MOLLER-TANK, Sven , KATAKOWSKI, Joseph , BAIK, Andrew , CYGNAR, Katherine , SAMAI, Poulami , CALAFATI, Philip
IPC分类号: C07K14/745 , A61K38/36
CPC分类号: C07K14/745 , A61K38/00
-
公开(公告)号:EP3386534A2
公开(公告)日:2018-10-17
申请号:EP16829343.9
申请日:2016-12-08
发明人: BAIK, Andrew , CYGNAR, Katherine
摘要: Compositions and methods for treating lysosomal storage diseases are disclosed. Biotherapeutic complexes containing an internalization effector binding domain and a lysosomal replacement enzyme activity are disclosed. The biotherapeutic complexes are capable of entering cells, segregating to the lysosome, and delivering the replacement enzyme activity to the lysosome.
-
公开(公告)号:EP3793591A1
公开(公告)日:2021-03-24
申请号:EP19728288.2
申请日:2019-05-17
-
公开(公告)号:EP3386534B1
公开(公告)日:2020-09-23
申请号:EP16829343.9
申请日:2016-12-08
发明人: BAIK, Andrew , CYGNAR, Katherine
-
公开(公告)号:EP4074331A1
公开(公告)日:2022-10-19
申请号:EP22169278.3
申请日:2016-12-08
发明人: BAIK, Andrew , CYGNAR, Katherine
摘要: Compositions and methods for treating lysosomal storage diseases are disclosed. Biotherapeutic complexes containing an internalization effector binding domain and a lysosomal replacement enzyme activity are disclosed. The biotherapeutic complexes are capable of entering cells, segregating to the lysosome, and delivering the replacement enzyme activity to the lysosome.
-
公开(公告)号:EP3448891A1
公开(公告)日:2019-03-06
申请号:EP17724667.5
申请日:2017-04-28
发明人: CYGNAR, Katherine , DELFINO, Frank
IPC分类号: C07K16/28
-
公开(公告)号:EP3644722A1
公开(公告)日:2020-05-06
申请号:EP18749203.8
申请日:2018-06-27
发明人: MUJICA, Alexander O. , GUSAROVA, Viktoria , WANG, Cheng , KYRATSOUS, Christos , POTOCKY, Terra , CYGNAR, Katherine , MARTIN, Joel
IPC分类号: A01K67/027 , C07K14/705 , C12N15/86
-
公开(公告)号:EP3635009A1
公开(公告)日:2020-04-15
申请号:EP18737065.5
申请日:2018-06-06
-
公开(公告)号:EP3319994A1
公开(公告)日:2018-05-16
申请号:EP16741208.9
申请日:2016-07-06
发明人: ANDREEV, Julian , THAMBI, Nithya , DELFINO, Frank , MARTIN, Joel , THURSTON, Gavin , CYGNAR, Katherine , PAPADOPOULOS, Nicholas
CPC分类号: C07K16/30 , A61K47/6803 , A61K47/6849 , A61K47/6851 , A61K47/6855 , A61K47/6879 , A61K2039/507 , C07K14/4702 , C07K16/1203 , C07K16/18 , C07K16/22 , C07K16/28 , C07K16/2833 , C07K16/2866 , C07K16/2869 , C07K16/2896 , C07K16/32 , C07K2317/21 , C07K2317/31 , C07K2317/35 , C07K2317/76 , C07K2317/77 , C07K2319/00 , C07K2319/30 , C12N9/6454
摘要: The present invention provides multispecific antigen-binding molecules and uses thereof. The multispecific antigen-binding molecules comprise a first antigen-binding domain that specifically binds a target molecule, and a second antigen-binding domain that specifically binds an internalizing effector protein. The multispecific antigen-binding molecules of the present invention can, in some embodiments, be bispecific antibodies that are capable of binding both a target molecule and an internalizing effector protein. In certain embodiments of the invention, the simultaneous binding of the target molecule and the internalizing effector protein by the multispecific antigen-binding molecule of the present invention results in the attenuation of the activity of the target molecule to a greater extent than the binding of the target molecule alone. In other embodiments of the invention, the target molecule is a tumor associated antigen, and the simultaneous binding of the tumor associated antigen and the internalizing effector protein by the multispecific antigen-binding molecule of the present invention causes or facilitates the targeted killing of tumor cells.
-
-
-
-
-
-
-
-
-